Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report 2017

November 2017 | 103 pages | ID: G89F1E6F615EN
QYResearch

Abstracts

In this report, the global Glucagon Like Peptide-1 (GLP-1) Agonists market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Glucagon Like Peptide-1 (GLP-1) Agonists for these regions, from 2012 to 2022 (forecast), covering

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Global Glucagon Like Peptide-1 (GLP-1) Agonists market competition by top manufacturers/players, with Glucagon Like Peptide-1 (GLP-1) Agonists sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novo Nordisk
• AstraZeneca
• Eli Lily
• GSK
• Sanofi
• Bristol-Myers Squibb
• Amylin

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Exenatied
• Liraglutide
• Lixisenatide
• Abliglutide
• Dulaglutide

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report 2017

1 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET OVERVIEW

1.1 Product Overview and Scope of Glucagon Like Peptide-1 (GLP-1) Agonists
1.2 Classification of Glucagon Like Peptide-1 (GLP-1) Agonists by Product Category
  1.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Exenatied
  1.2.4 Liraglutide
  1.2.5 Lixisenatide
  1.2.6 Abliglutide
  1.2.7 Dulaglutide
1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market by Application/End Users
  1.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Pharmacy
1.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market by Region
  1.4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Glucagon Like Peptide-1 (GLP-1) Agonists Status and Prospect (2012-2022)
  1.4.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Status and Prospect (2012-2022)
  1.4.4 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Status and Prospect (2012-2022)
  1.4.5 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Status and Prospect (2012-2022)
  1.4.7 India Glucagon Like Peptide-1 (GLP-1) Agonists Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Glucagon Like Peptide-1 (GLP-1) Agonists (2012-2022)
  1.5.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2022)
  1.5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2012-2022)

2 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Competition by Players/Suppliers
  2.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists (Volume and Value) by Type
  2.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Type (2012-2017)
  2.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Type (2012-2017)
2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists (Volume and Value) by Region
  2.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Region (2012-2017)
  2.3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Region (2012-2017)
2.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists (Volume) by Application

3 UNITED STATES GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Value (2012-2017)
  3.1.1 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)
  3.1.2 United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2012-2017)
  3.1.3 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Trend (2012-2017)
3.2 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share by Players
3.3 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share by Type
3.4 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share by Application

4 CHINA GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS (VOLUME, VALUE AND SALES PRICE)

4.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Value (2012-2017)
  4.1.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)
  4.1.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2012-2017)
  4.1.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Trend (2012-2017)
4.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share by Players
4.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share by Type
4.4 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share by Application

5 EUROPE GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Value (2012-2017)
  5.1.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)
  5.1.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Trend (2012-2017)
5.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share by Players
5.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share by Type
5.4 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share by Application

6 JAPAN GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Value (2012-2017)
  6.1.1 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)
  6.1.2 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Trend (2012-2017)
6.2 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share by Players
6.3 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share by Type
6.4 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share by Application

7 SOUTHEAST ASIA GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Value (2012-2017)
  7.1.1 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Trend (2012-2017)
7.2 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share by Players
7.3 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share by Type
7.4 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share by Application

8 INDIA GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS (VOLUME, VALUE AND SALES PRICE)

8.1 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Value (2012-2017)
  8.1.1 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)
  8.1.2 India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2012-2017)
  8.1.3 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Trend (2012-2017)
8.2 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share by Players
8.3 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share by Type
8.4 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share by Application

9 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Novo Nordisk
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 AstraZeneca
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Eli Lily
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 GSK
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Sanofi
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Bristol-Myers Squibb
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Amylin
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview

10 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MAUFACTURING COST ANALYSIS

10.1 Glucagon Like Peptide-1 (GLP-1) Agonists Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
10.3 Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET FORECAST (2017-2022)

14.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price and Trend Forecast (2017-2022)
14.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Type (2017-2022)
  14.3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Forecast by Type (2017-2022)
  14.3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast by Type (2017-2022)
14.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Type (Product Category) in 2016
Figure Exenatied Product Picture
Figure Liraglutide Product Picture
Figure Lixisenatide Product Picture
Figure Abliglutide Product Picture
Figure Dulaglutide Product Picture
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Million USD) by Regions (2012-2022)
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Players/Suppliers
Figure 2017 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Players/Suppliers
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Players
Table 2017 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Players
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Market Share by Type (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type (2012-2017)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate by Type (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type (2012-2017)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate by Type (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Region (2012-2017)
Figure Sales Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Region (2012-2017)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate by Region in 2016
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Region (2012-2017)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate by Region in 2016
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Region (2012-2017)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region in 2016
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Application (2012-2017)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2012-2017)
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) Trend (2012-2017)
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Players (2012-2017)
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Players (2012-2017)
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Players in 2016
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Type (2012-2017)
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Type (2012-2017)
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Type in 2016
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Application (2012-2017)
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Application (2012-2017)
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Application in 2016
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) Trend (2012-2017)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Players (2012-2017)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Players (2012-2017)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Players in 2016
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Type (2012-2017)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Type (2012-2017)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Type in 2016
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Application (2012-2017)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Application (2012-2017)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Application in 2016
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) Trend (2012-2017)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Players (2012-2017)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Players (2012-2017)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Players in 2016
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Type (2012-2017)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Type (2012-2017)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Type in 2016
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Application (2012-2017)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Application (2012-2017)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Application in 2016
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Players (2012-2017)
Table Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Players (2012-2017)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Players in 2016
Table Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Type (2012-2017)
Table Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Type (2012-2017)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Type in 2016
Table Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Application (2012-2017)
Table Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Application (2012-2017)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Application in 2016
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Players in 2016
Table Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Type in 2016
Table Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Application in 2016
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) Trend (2012-2017)
Table India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Players (2012-2017)
Table India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Players (2012-2017)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Players in 2016
Table India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Type (2012-2017)
Table India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Type (2012-2017)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Type in 2016
Table India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Application (2012-2017)
Table India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Application (2012-2017)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Application in 2016
Table Novo Nordisk Basic Information List
Table Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (2012-2017)
Figure Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales Global Market Share (2012-2017
Figure Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Global Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (2012-2017)
Figure AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales Global Market Share (2012-2017
Figure AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Global Market Share (2012-2017)
Table Eli Lily Basic Information List
Table Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (2012-2017)
Figure Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales Global Market Share (2012-2017
Figure Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Global Market Share (2012-2017)
Table GSK Basic Information List
Table GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (2012-2017)
Figure GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales Global Market Share (2012-2017
Figure GSK Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (2012-2017)
Figure Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales Global Market Share (2012-2017
Figure Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Global Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales Global Market Share (2012-2017
Figure Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Global Market Share (2012-2017)
Table Amylin Basic Information List
Table Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (2012-2017)
Figure Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales Global Market Share (2012-2017
Figure Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
Table Raw Materials Sources of Glucagon Like Peptide-1 (GLP-1) Agonists Major Players in 2016
Table Major Buyers of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Distributors/Traders List
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share Forecast by Regions in 2022
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share Forecast by Regions in 2022
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Forecast by Type (2017-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share Forecast by Type (2017-2022)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Forecast by Application (2017-2022)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources